Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $3.43M | ﹤0.01% |
60,457
+48,057
| +388% | +$2.69M |
|
2002
Acme United Corp
ACU
$221M
| $3.43M | ﹤0.01% |
171,300
+10,406
| +6% | +$214K |
|
2003
Pearson
PSO
$10.1B
| $3.42M | ﹤0.01% |
378,400
-15,500
| -4% | -$161K |
|
|
AVDL
2004
DELISTED
Avadel Pharmaceuticals
AVDL
| $3.42M | ﹤0.01% |
822,006
+19,400
| +2% | +$48.6K |
|
2005
CSP Inc
CSPI
$84.4M
| $3.42M | ﹤0.01% |
509,500
| – | – |
|
2006
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.12B
| $3.42M | ﹤0.01% |
67,700
-158
| -0.2% | -$7.96K |
|
|
GHG
2007
GreenTree Hospitality
GHG
$113M
| $3.41M | ﹤0.01% |
340,748
+69,551
| +26% | +$787K |
|
|
MPX
2008
DELISTED
Marine Products Corp
MPX
| $3.41M | ﹤0.01% |
240,502
+6,100
| +3% | +$90.7K |
|
2009
Riverview Bancorp
RVSB
$108M
| $3.4M | ﹤0.01% |
460,417
+33,610
| +8% | +$261K |
|
2010
Cathay General Bancorp
CATY
$4.26B
| $3.4M | ﹤0.01% |
97,771
+3,700
| +4% | +$129K |
|
2011
Upland Software
UPLD
$12.9M
| $3.39M | ﹤0.01% |
9,732
+8,300
| +580% | +$3.45M |
|
|
TRUE
2012
DELISTED
TrueCar
TRUE
| $3.39M | ﹤0.01% |
996,500
+634,000
| +175% | +$2.81M |
|
2013
Donaldson
DCI
$11.1B
| $3.39M | ﹤0.01% |
+65,029
| New | +$3.22M |
|
2014
Aspen Aerogels
ASPN
$391M
| $3.37M | ﹤0.01% |
569,531
+35,200
| +7% | +$224K |
|
2015
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $3.37M | ﹤0.01% |
+89,765
| New | +$3.34M |
|
|
GNMK
2016
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.37M | ﹤0.01% |
555,500
+216,400
| +64% | +$1.35M |
|
2017
Flexsteel Industries
FLXS
$313M
| $3.36M | ﹤0.01% |
226,418
+30,925
| +16% | +$504K |
|
|
CLUB
2018
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $3.36M | ﹤0.01% |
2,046,552
+53,890
| +3% | +$95.1K |
|
2019
Kodiak Sciences
KOD
$2.62B
| $3.34M | ﹤0.01% |
232,545
+111,331
| +92% | +$1.45M |
|
|
TOUR
2020
Tuniu
TOUR
$54.1M
| $3.34M | ﹤0.01% |
112,078
+1,900
| +2% | +$61.3K |
|
|
CALA
2021
DELISTED
Calithera Biosciences, Inc
CALA
| $3.33M | ﹤0.01% |
53,940
+16,430
| +44% | +$1.32M |
|
|
DALN
2022
DELISTED
DallasNews
DALN
| $3.33M | ﹤0.01% |
221,839
+4,921
| +2% | +$70.6K |
|
|
SRGA
2023
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $3.32M | ﹤0.01% |
38,786
-8,806
| -19% | -$940K |
|
2024
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
| $3.31M | ﹤0.01% |
113,556
-1,544
| -1% | -$45.3K |
|
2025
Kingstone Companies
KINS
$293M
| $3.27M | ﹤0.01% |
383,900
-2,000
| -0.5% | -$17K |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.